Female Sexual Dysfunction, Dr. Weyrich's Naturopathic Functional Medicine Notebook

Overview

Complimentary and alternative treatments for female sexual dysfunction that are considered below include:

Neurotransmitter Balancing

Please see conventional, complimentary and alternative medical treatments for important background information regarding the different types of medical treatments discussed on this page. Naturopathic, Complimentary and Alternative treatments that may be considered include:

Treatment

Naturopathic, Complimentary and Alternative Treatments

Testosterone

Testosterone benefits libido in both males and females (although therapeutic levels are different) [Friedman2013, pp 63, 74], [Davis2001], [Davis2005], [Davis2009].

Neurotransmitter Balancing

Neuro Research [Hinz2015] reports that chronic diseases such as Female Sexual Dysfunction can be benefited by balancing neurotransmitter levels in the body.

Dr. Weyrich has been trained in neurotransmitter balancing protocols, but has not treated Female Sexual Dysfunction using this technique.

Please see What is Neurotransmitter Balancing? for more information.

ICD-10

F10.181 Alcohol abuse with alcohol-induced sexual dysfunction
F10.281 Alcohol dependence with alcohol-induced sexual dysfunction
F52.0 Hypoactive sexual desire disorder
F52.1 Sexual aversion disorder
F52.22 Female sexual arousal disorder
F52.31 Female orgasmic disorder
F52.5 Vaginismus not due to a substance or known physiological condition
F52.6 Dyspareunia not due to a substance or known physiological condition
F52.8 Other sexual dysfunction not due to a substance or known physiological condition
F52.9 Unspecified sexual dysfunction not due to a substance or known physiological condition
F66 Other sexual disorders (e.g. increased libido)
See also Gender Identity Disorders and Paraphilias

References

[Davis2001] Susan R Davis, Jane Tran. Testosterone influences libido and well being in women. Trends in Endocrinology & Metabolism 12(1):33-37 (January 2001). PMID: 11137039 Full text: https://www.cell.com/trends/endocrinology-metabolism/fulltext/S1043-2760(00)00333-7 Accessed: 11/1/2019.
[Davis2005] Susan R Davis, Michele Moreau, Robin Kroll, Céline Bouchard, Nick Panay, Margery Gass, Glenn D Braunstein, Angelica Linden Hirschberg, Cynthia Rodenberg, Simon Pack, Helga Koch, Alain Moufarege, John Studd. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med. 2008 Nov 6;359(19):2005-17. PMID: 18987368 Full text: https://www.nejm.org/doi/full/10.1056/NEJMoa0707302 Accessed: 11/01/2019.
[Davis2009] Susan R Davis. Testosterone for low libido in postmenopausal women not using systemic oestrogen therapy. Med J Aust. 2009 Aug 3;191(3):134-5. PMID: 19645638
[Friedman2013] Edward Friedman, William Cane. The New Testosterone Treatment: How You and Your Doctor Can Fight Breast Cancer, Prostate Cancer, and Alzheimer's. Prometheus Books (2013). Amazon

This is an excellent presentation of recent advances in the understanding of hormone receptors and their relationship to prostate cancer, breast cancer, and Alzheimer's disease.
However, the author does not consider the possibility of epigenetic changes due to long-term exposure to hormones that may span multiple generations of cells, resulting in cumulative changes in gene expression.
In addition, the author proposes that the lengthening of telomeres is a necessary step in cell immortalization in cancer. Dr. Weyrich notes that other researchers have proposed lengthening of telomeres to be a positive outcome that should be promoted by various interventions.
[Hinz2015] Martin C Hinz. Managing Relative Nutritional Deficiencies associated with the centrally acting monoamines (Serotonin, Dopamine, Norepinephrine and/or Epinephrine. Neuro Research Clinics. AMA Category 1 Continuing Medical Education seminar. September 26, 2015, Phoenix, AZ.